title: Periprocedural management and approach to bleeding in patients taking dabigatran.
authors.affiliation: Department of Medicine, Thrombosis and Atherosclerosis Research Institute, 237 Barton St E, Hamilton, Ontario L8L 2X2, Canada. weitzj@taari.ca
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Quinlan
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications; D001562:Benzimidazoles / Q000627:therapeutic use*; D000075202:Contraindications; D000069604:Dabigatran; D004305:Dose-Response Relationship, Drug; D017707:Erythrocyte Transfusion; D006207:Half-Life; D006396:Hematemesis / Q000628:therapy*; D006801:Humans; D008297:Male; D008551:Melena / Q000628:therapy*; D010949:Plasma; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control; D013997:Time Factors; D028761:Withholding Treatment; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran